The lawsuit says the agency failed to address concerns that the use of medically important antibiotics for disease prevention in livestock and poultry poses a threat to human health.
A CIDRAP-ASP report on the global burden of typhoid, the emergence of drug-resistant strains, and the role that typhoid conjugate vaccine campaigns could play in typhoid prevention and control.
Patients and patient advocacy groups say their input can help companies design better clinical trials.
True stories from scientists and pateients.
You can find all of CIDRAP-ASP's previous webinars on our YouTube channel.
Take the latest edition of our monthly quiz.
Help support our work on antimicrobial stewardship.
Be in the know about antimicrobial stewardship.
Our antimicrobial resistance factsheet
Antimicrobial resistance occurs when microbes, such as bacteria, evolve the ability to survive exposure to medicines previously used to treat them. Visit the antimicrobial resistance factsheet to learn more.
The Antimicrobial Resistance Toolkit
We developed a toolkit aimed at community practitioners and patients to provide basic information on antimicrobial resistance and responsible use of antibiotics. You can view and download the Toolkit here.
One Health Antimicrobial Stewardship
We are currently developing educational modules to raise awareness and increase the knowledge base about practical antibiotic stewardship implementation among veterinarians.
In this summary of the most recently updated Histoplasmosis Porto Alegre Manifesto, following the May 2022 Brazilian Histoplasmosis Meeting, the authors call for urgent improvements to the availability of Histoplasma antigen testing and liposomal amphotericin B antifungal treatment.
Increasing numbers of infections in animals associated with resistant bacteria pose a challenge for veterinarians in the United States (US) and around the world. This review article presents existing efforts in the US, as well as challenges and opportunities, related to surveillance of AMR in veterinary medicine.
This study surveyed 235 centers across 40 countries and territories in the Asia-Pacific region from June 2021 to April 2022 to understand connections between the availability of fungal diagnostic and treatment capacity and Gross Domestic Product (GDP) per capita, acknowledging that national economic factors play a significant role in access to fungal disease diagnosis.